PRISYM ID, a leading provider of regulated content and label management solutions, announced today that Global Clinical Trial Supplies Specialist RxSource has invested in the innovative PRISYM 360 clinical labelling platform. The software will enable RxSource to optimize its demand-led secondary packaging and labelling services, and supply medicines faster.
RxSource Invested in PRISYM 360 Clinical Labelling Platform
Posted by MyTechMag under NewsFrom https://www.mytechmag.com 1416 days ago
Who Voted for this Story
Subscribe
Comments